|
|
||||||||
Ann Thorac Surg 1988;45:50-55
© 1988 The Society of Thoracic Surgeons
From the Department of Cardiothoracic Surgery, University of Cape Town Medical School, Cape Town, South Africa
Accepted for publication August 24, 1987.
* Address reprint requests to Dr. Novitzky, Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City, OK 73112
A significant reduction (p < 0.0001) in plasma-free triiodothyronine (T3), which is known to have an inotropic effect, has been documented in patients undergoing open-heart procedures. To investigate the effect of this observation, 22 pigs underwent 2 hours (Group 1, r = 10) or 3 hours (Group 2, r = 12) of myocardial ischemia during cardiopulmonary bypass (CPB) at 26°C; the myocardium was protected by cardioplegic solution and cold saline solution at 30-minute intervals. After the pig was rewarmed to 37°C, CPB was discontinued, and measurements of hemodynamic function were made 10 and 70 minutes later. Half of the pigs (Subgroup B) received 6 µg of T3 intravenously immediately after removal of the aortic cross-clamp; the remainder (Subgroup A) received no T3. After 2 hours of ischemia, untreated pigs showed significantly reduced myocardial function 10 minutes after discontinuation of CPB. By 70 minutes after the end of CPB, 2 of 5 untreated pigs (Subgroup A) had died of low cardiac output, but all 5 treated pigs (Subgroup B) survived. After 3 hours of ischemia, both groups showed some reduced function at 10 minutes, though the reduction was more marked in untreated animals. By 70 minutes, 4 of 6 untreated pigs had died of myocardial failure and all treated pigs remained alive (p < 0.03). Surviving pigs in both groups still demonstrated some reduced function compared with values obtained before CPB. When all pigs are considered together, overall survival of those that did not receive T3 was significantly less than those that did (p < 0.006). T3 clearly has a significant beneficial inotropic effect when administered after a period of myocardial ischemia and CPB; its administration may be indicated in patients undergoing open-heart operations.
This article has been cited by other articles:
![]() |
P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mackie, K. L. Booth, J. W. Newburger, K. Gauvreau, S. A. Huang, P. C. Laussen, J. A. DiNardo, P. J. del Nido, J. E. Mayer Jr, R. A. Jonas, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 810 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Portman, K. Qian, J. Krueger, and X.-H. Ning Direct action of T3 on phosphorylation potential in the sheep heart in vivo Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2484 - H2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sirlak, L. Yazicioglu, M. B. Inan, S. Eryilmaz, R. Tasoz, A. Aral, and U. Ozyurda Oral thyroid hormone pretreatment in left ventricular dysfunction Eur J Cardiothorac Surg, October 1, 2004; 26(4): 720 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carrel, F. Eckstein, L. Englberger, R. Mury, and P. Mohacsi Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature Eur J Heart Fail, October 1, 2002; 4(5): 577 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Portman, C. Fearneyhough, X.-H. Ning, B. W. Duncan, G. L. Rosenthal, and F. M. Lupinetti Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 604 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest Ann. Thorac. Surg., November 1, 1999; 68(5): 1934 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Mullis-Jansson, M. Argenziano, S. Corwin, S. Homma, A. D. Weinberg, M. Williams, E. A. Rose, and C. R. Smith A RANDOMIZED DOUBLE-BLIND STUDY OF THE EFFECT OF TRIIODOTHYRONINE ON CARDIAC FUNCTION AND MORBIDITY AFTER CORONARY BYPASS SURGERY J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1128 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murai, Y. Katayama, T. Yamada, T. Imazeki, Y. Irie, H. Kiyama, Y. Sato, I. Hata, H. Yoshida, and M. Mukouyama Thyroid Hormone and Myocardial Metabolism After Heart Surgery in Dogs Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 13 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu, A. S. Clanachan, and G. D. Lopaschuk Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E392 - E399. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. DiPierro, J. E. Bavaria, E. B. Lankford, D. J. Polidori, M. A. Acker, J. T. Streicher, and T. J. Gardner Triiodothyronine Optimizes Sheep Ventriculoarterial Coupling for Work Efficiency Ann. Thorac. Surg., September 1, 1996; 62(3): 662 - 669. [Abstract] [Full Text] |
||||
![]() |
E. Bennett-Guerrero, J. L. Jimenez, W. D. White, E. B. D'Amico, B. I. Baldwin, D. A. Schwinn, Duke T3 Study Group, N. P. Bouknight, C. M. Chuey, F. M. Clements, et al. Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial JAMA, March 6, 1996; 275(9): 687 - 692. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3' triiodo-L-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford, and F. G. Spinale PRETREATMENT WITH 3,5,3' TRIIODO-L-THYRONINE (T3): Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 315 - 327. [Abstract] [Full Text] |
||||
![]() |
J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465. [Abstract] [Full Text] |
||||
![]() |
B. Murzi, G. Iervasi, S. Masini, R. Moschetti, V. Vanini, G. Zucchelli, and A. Biagini Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 481 - 485. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford, S. Kato, and F. G. Spinale The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and {beta}-adrenergic responsiveness in dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 672 - 679. [Abstract] [Full Text] |
||||
![]() |
R. D. Mainwaring, J. J. Lamberti, G. F. Billman, and J. C. Nelson Suppression of the pituitary thyroid axis after cardiopulmonary bypass in the neonate Ann. Thorac. Surg., October 1, 1994; 58(4): 1078 - 1082. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, R. Mukherjee, M. R. Zile, and F. G. Spinale Direct effects of acute administration of 3, 5, 3' triiodo-L-thyronine on myocyte function Ann. Thorac. Surg., September 1, 1994; 58(3): 851 - 856. [Abstract] [PDF] |
||||
![]() |
T. H. Jones, S. M. Hunter, A. Price, and G. D. Angelini Should thyroid function be assessed before cardiopulmonary bypass operations? Ann. Thorac. Surg., August 1, 1994; 58(2): 434 - 436. [Abstract] [PDF] |
||||
![]() |
S. Buket, A. Alayunt, M. Ozbaran, A. Hamulu, B. Discigil, B. Cetindag, H. Ozkilic, Z. Balkan, O. Bilkay, and I. Durmaz Effect of pulsatile flow during cardiopulmonary bypass on thyroid hormone metabolism Ann. Thorac. Surg., July 1, 1994; 58(1): 93 - 96. [Abstract] [PDF] |
||||
![]() |
C. M. Dyke, M. Ding, A. S. Abd-Elfattah, K. Loesser, R. J. Dignan, A. S. Wechsler, and D. R. Salter Effects of triiodothyronine supplementation after myocardial ischemia Ann. Thorac. Surg., August 1, 1993; 56(2): 215 - 222. [Abstract] [PDF] |
||||
![]() |
F. W. Holland II, P. S. Brown Jr, and R. E. Clark Acute severe postischemic myocardial depression reversed by triiodothyronine Ann. Thorac. Surg., August 1, 1992; 54(2): 301 - 305. [Abstract] [PDF] |
||||
![]() |
C. M. Dyke, T. Yeh Jr, J. D. Lehman, A. Abd-Elfattah, M. Ding, A. S. Wechsler, and D. R. Salter Triiodothyronine-enhanced left ventricular function after ischemic injury Ann. Thorac. Surg., July 1, 1991; 52(1): 14 - 19. [Abstract] [PDF] |
||||
![]() |
F. W. Holland II, P. S. Brown Jr, B. D. Weintraub, and R. E. Clark Cardiopulmonary bypass and thyroid function: A "euthyroid sick syndrome" Ann. Thorac. Surg., July 1, 1991; 52(1): 46 - 50. [Abstract] [PDF] |
||||
![]() |
R. E. Clark Triiodothyronine: To be or not to be, that is the question Ann. Thorac. Surg., January 1, 1991; 51(1): 5 - 5. [PDF] |
||||
![]() |
D. Novitzky, N. Matthews, D. Shawley, D. K. C. Cooper, and N. Zuhdi Triiodothyronine in the recovery of stunned myocardium in dogs Ann. Thorac. Surg., January 1, 1991; 51(1): 10 - 17. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |